Budget Amount *help |
¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2014: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2013: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2012: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Outline of Final Research Achievements |
Patients with childhood acute lymphoblastic leukemia (ALL) in high risk recur about 30%. Recently, IKZF1 alteration in genomic DNA has been found as a prognostic factor. To elucidate the role of the IKZF1 alteration, we developed childhood ALL model cells with IKZF1 mutations. We investigated the relationship between the IKZF1 alteration and anti-cancer drug sensitivity which are frequently used in childhood ALL. The results showed the sensitivity to the several drugs may be dependent on the IKZF1 alteration.
|